BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 27974723)

  • 1. Genome and Epigenome Editing in Mechanistic Studies of Human Aging and Aging-Related Disease.
    Lau CH; Suh Y
    Gerontology; 2017; 63(2):103-117. PubMed ID: 27974723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas-Based Epigenome Editing: Advances, Applications, and Clinical Utility.
    Goell JH; Hilton IB
    Trends Biotechnol; 2021 Jul; 39(7):678-691. PubMed ID: 33972106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editing the Epigenome: Reshaping the Genomic Landscape.
    Holtzman L; Gersbach CA
    Annu Rev Genomics Hum Genet; 2018 Aug; 19():43-71. PubMed ID: 29852072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9 guided genome and epigenome engineering and its therapeutic applications in immune mediated diseases.
    Singh DD; Hawkins RD; Lahesmaa R; Tripathi SK
    Semin Cell Dev Biol; 2019 Dec; 96():32-43. PubMed ID: 31112800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenome Editing in the Brain.
    Bashtrykov P; Jeltsch A
    Adv Exp Med Biol; 2017; 978():409-424. PubMed ID: 28523558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome and Epigenome Editing to Treat Disorders of the Hematopoietic System.
    Mussolino C; Alzubi J; Pennucci V; Turchiano G; Cathomen T
    Hum Gene Ther; 2017 Nov; 28(11):1105-1115. PubMed ID: 28806883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas mediated epigenome editing for cancer therapy.
    Ansari I; Chaturvedi A; Chitkara D; Singh S
    Semin Cancer Biol; 2022 Aug; 83():570-583. PubMed ID: 33421620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo epigenome editing and transcriptional modulation using CRISPR technology.
    Lau CH; Suh Y
    Transgenic Res; 2018 Dec; 27(6):489-509. PubMed ID: 30284145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical and Light Inducible Epigenome Editing.
    Zhao W; Wang Y; Liang FS
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32028669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decoding the noncoding genome via large-scale CRISPR screens.
    Shukla A; Huangfu D
    Curr Opin Genet Dev; 2018 Oct; 52():70-76. PubMed ID: 29913329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editing the Epigenome: Overview, Open Questions, and Directions of Future Development.
    Rots MG; Jeltsch A
    Methods Mol Biol; 2018; 1767():3-18. PubMed ID: 29524127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered anti-CRISPR proteins for optogenetic control of CRISPR-Cas9.
    Bubeck F; Hoffmann MD; Harteveld Z; Aschenbrenner S; Bietz A; Waldhauer MC; Börner K; Fakhiri J; Schmelas C; Dietz L; Grimm D; Correia BE; Eils R; Niopek D
    Nat Methods; 2018 Nov; 15(11):924-927. PubMed ID: 30377362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Mediated Epigenome Editing.
    Enríquez P
    Yale J Biol Med; 2016 Dec; 89(4):471-486. PubMed ID: 28018139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome engineering tools for building cellular models of disease.
    Lin J; Musunuru K
    FEBS J; 2016 Sep; 283(17):3222-31. PubMed ID: 27218233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-Based Engineering of the Epigenome.
    Pulecio J; Verma N; Mejía-Ramírez E; Huangfu D; Raya A
    Cell Stem Cell; 2017 Oct; 21(4):431-447. PubMed ID: 28985525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epigenome editors: How tools such as CRISPR offer new details about epigenetics.
    Willyard C
    Nat Med; 2017 Aug; 23(8):900-903. PubMed ID: 28777784
    [No Abstract]   [Full Text] [Related]  

  • 17. Epigenetic editing: Dissecting chromatin function in context.
    Policarpi C; Dabin J; Hackett JA
    Bioessays; 2021 May; 43(5):e2000316. PubMed ID: 33724509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR Tools for Physiology and Cell State Changes: Potential of Transcriptional Engineering and Epigenome Editing.
    Breunig CT; Köferle A; Neuner AM; Wiesbeck MF; Baumann V; Stricker SH
    Physiol Rev; 2021 Jan; 101(1):177-211. PubMed ID: 32525760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
    Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
    Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Toolboxes for Precision Genome/Epigenome Editing and Imaging of Epigenetics.
    Nomura W
    Chem Rec; 2018 Dec; 18(12):1717-1726. PubMed ID: 30066981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.